Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
J Cardiovasc Pharmacol ; 41(4): 657-64, 2003 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-12658069

RESUMEN

Cannabinoids elicit hypotension mainly via activated CB(1) receptors and show complex cardiovascular actions. Effects on human heart muscle have not been studied yet. Isolated human atrial heart muscle preparations were stimulated by electrical field with 1 Hz to contract isometrically at optimal length and were challenged with the endogenous cannabinoid arachidonyl ethanolamide (anandamide), the metabolically stable analogue R-methanandamide, and the potent synthetic CB(1) receptor agonist HU-210. Anandamide dose-dependently decreased systolic force (82.2 +/- 4.8% and 60.8 +/- 6.8% of maximal systolic force for 0.1 and 1 microM, respectively, P < 0.05). The selective CB(1) receptor antagonist AM-251 (1 microM, P < 0.05), but not the CB(2) receptor antagonist, AM-630 (1 microM), the nitric oxide synthase inhibitor N omega-nitro-l-arginine methyl ester (l-NAME) (500 microM), or the cyclooxygenase inhibitor indomethacin (100 microM), prevented the effect. Contrary to indomethacin, l-NAME alone showed negative inotropic effects (72.1 +/- 3.54%, P < 0.001). The R-methanandamide (1 microM: 50.4 +/- 3.5%, P < 0.001) and HU-210 (1 microM: 60.1 +/- 3.8%, P < 0.001) had similar negative inotropic effects. The existence of CB(1) receptors on heart muscle was verified using Western blot analysis and immunofluorescence staining. The conclusion is that anandamide, R-methanandamide, and HU-210 decrease contractile performance in human atrial muscle via CB(1) receptors.


Asunto(s)
Función Atrial/efectos de los fármacos , Cannabinoides/farmacología , Contracción Miocárdica/efectos de los fármacos , Miocardio , Receptores de Droga/agonistas , Receptores de Droga/metabolismo , Función Atrial/fisiología , Cannabinoides/metabolismo , Depresión Química , Atrios Cardíacos/efectos de los fármacos , Atrios Cardíacos/metabolismo , Humanos , Técnicas In Vitro , Contracción Miocárdica/fisiología , Miocardio/metabolismo , Receptores de Cannabinoides
2.
Biochem Biophys Res Commun ; 298(1): 163-8, 2002 Oct 18.
Artículo en Inglés | MEDLINE | ID: mdl-12379235

RESUMEN

One major function of the creatine kinase system is to maintain energy demand of myofibrillar contraction processes. Loss of the CK-system led to adaptations in skeletal muscle. To analyze the impact on myocardial function contractile parameters and intracellular calcium metabolism of transgenic mice lacking mitochondrial CK (ScCKmit(-/-)) alone or both mitochondrial and cytoplasmic ScCK (CK(-/-)) were investigated compared to wild type at various workload conditions using isolated intact muscle fibers. Force development at baseline conditions, force-frequency relationship (60-600/min), and rapid frequency switch (60-600/min) were unaltered in myocardium of transgenic mice compared to wild type. Intracellular calcium metabolism revealed unchanged amplitude of the intracellular calcium transients (ICT), refilling of the sarcoplasmic reticulum (calcium reuptake, post-rest behavior) in the ScCKmit(-/-) and CK(-/-) mice. The results demonstrate the effectiveness of myocardial energy-recruiting compensatory mechanisms at baseline as well as under stress conditions in CK depleted myocardium of transgenic mice.


Asunto(s)
Calcio/metabolismo , Creatina Quinasa/genética , Isoenzimas/genética , Contracción Miocárdica , Miocardio/metabolismo , Adaptación Fisiológica , Animales , Forma MB de la Creatina-Quinasa , Forma Mitocondrial de la Creatina-Quinasa , Técnicas de Cultivo , Estimulación Eléctrica , Contracción Isométrica , Cinética , Ratones , Ratones Noqueados , Ratones Transgénicos , Fibras Musculares Esqueléticas/metabolismo , Fibras Musculares Esqueléticas/fisiología , Relajación Muscular
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...